134 related articles for article (PubMed ID: 3680603)
1. Alprazolam kinetics following sublingual and oral administration.
Scavone JM; Greenblatt DJ; Shader RI
J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.
Scavone JM; Greenblatt DJ; Goddard JE; Friedman H; Harmatz JS; Shader RI
Eur J Clin Pharmacol; 1992; 42(4):439-43. PubMed ID: 1516609
[TBL] [Abstract][Full Text] [Related]
3. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing.
Luscombe DK
Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846
[TBL] [Abstract][Full Text] [Related]
4. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.
Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
Neuropsychobiology; 2007; 55(3-4):203-12. PubMed ID: 17878744
[TBL] [Abstract][Full Text] [Related]
5. Enhanced bioavailability of triazolam following sublingual versus oral administration.
Scavone JM; Greenblatt DJ; Friedman H; Shader RI
J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
[TBL] [Abstract][Full Text] [Related]
6. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet.
Erdman K; Stypinski D; Combs M; Witt P; Stiles M; Pollock S
Pharmacotherapy; 2007 Aug; 27(8):1120-4. PubMed ID: 17655512
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine serum concentrations following sublingual and oral doses.
Brown GR; Fraser DG; Castile JA; Gaudreault P; Platt DR; Friedman PA
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):283-6. PubMed ID: 3733277
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of flunitrazepam (Rohypnol) following oral and sublingual administration.
Hüttel MS; Bang U; Flachs H
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):221-3. PubMed ID: 3710635
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Price TM; Blauer KL; Hansen M; Stanczyk F; Lobo R; Bates GW
Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
[TBL] [Abstract][Full Text] [Related]
11. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
Smith RB; Gwilt PR; Wright CE
Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].
Woodcock BG; Wörner P; Rietbrock N; Schwabe L; Frömming KH
Arzneimittelforschung; 1982; 32(12):1567-71. PubMed ID: 6891597
[TBL] [Abstract][Full Text] [Related]
13. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
[TBL] [Abstract][Full Text] [Related]
15. A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration.
Wang Y; Roy A; Sun L; Lau CE
Drug Metab Dispos; 1999 Aug; 27(8):855-9. PubMed ID: 10421610
[TBL] [Abstract][Full Text] [Related]
16. Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration.
Scavone JM; Luna BG; Harmatz JS; von Moltke L; Greenblatt DJ
Biopharm Drug Dispos; 1990 Apr; 11(3):185-9. PubMed ID: 2328304
[TBL] [Abstract][Full Text] [Related]
17. Disposition of alprazolam in human volunteers. Differences between genders.
Kristjánsson F; Thorsteinsson SB
Acta Pharm Nord; 1991; 3(4):249-50. PubMed ID: 1781916
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
Ciraulo DA; Barnhill JG; Boxenbaum HG; Greenblatt DJ; Smith RB
J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
20. Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
Schaff EA; DiCenzo R; Fielding SL
Contraception; 2005 Jan; 71(1):22-5. PubMed ID: 15639067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
